In an attempt to enhance targeting efficiency of HER2-targing vector, we have combined the HER2 binding amino acids sequences of these two important peptides to construct a HER2-targeted hybrid peptide as an SPECT imaging probe in order to evaluate its tumor targeting potential in vivo in subcutaneous HER2-positive human breast cancer xenografts models. The gene discussed is ERBB2; the disease is breast carcinoma.